More recently, we and others have detected a marked decrease in the formation of pulmonary metastases in breast cancer upon CD151 deletion or knockdown in MMTV-ErbB2 or MMTV-PyMT transgenic or xenograft model [28,32,38]. Here, CD151 is linked to breast cancer.